Study Tracks Effect of Pre-Launch Buzz for New Drugs

Nielsen BuzzMetrics tracked pre- and post-approval buzz of four new drugs, finding that those that generated even small amounts of buzz prior to approval enjoyed a comparatively large and sustained increase in discussion among relevant populations.

Full Article from Marketwire

Posted by: Lara Hejtmanek on 05-05, 04:36PM | DTC Marketing
« Older Therapists Using IM to Counsel Patients | DTC Survey Indicates Increased Focus on Education, Away From Acquisition Newer »
Comments:
Post a comment:
















Keep Updated

Monthly email updates on online pharma marketing.
separator.gif
About GreaterRx
GreaterRx is an industry resource brought to you by the interactive marketing experts at Greater Than One.

Contact us with questions, comments, or to suggest an article.
Greater Than One
separator.gif